ARPA-I is the newest addition to a long line of successful ARPAs that continue to deliver breakthrough innovations across the defense, intelligence, energy, and health sectors.
Do you have ideas that could inform an ambitious project that FESI has a comparative advantage pursuing? We want to hear it.
Friends of FESI have identified priority use cases to inform project ideas.
The CHIPS and Science Act establishes a compelling vision for U.S. innovation and place-based industrial policy, but that vision is already being hampered by tight funding.
Here’s how CHIPS and Science funding is shaping up in the battle over the federal budget.
Even though the COVID emergency is over, personal appearance waivers should be a standing policy in low risk cases.
Before releasing a new, powerful system like GPT-4 to millions of users, we must ask: “How can we know that this system is safe, trustworthy, and reliable enough to be released?”
The J1 visa Exchange Visitor Program, a pivotal mechanism fostering global cultural exchange and dissemination of specialized knowledge, remains regrettably stagnant since its last renewal in 2009.
Investing in oxygen as a utility through on-demand infrastructure can improve access and mortality rates globally. Healthcare experts propose how an international coalition led by USAID can transform the medical oxygen marketplaces of low- and middle-income countries to ensure every patient has the oxygen they need.
A nondefense-only cap approach may mean estimated cuts of 28% in FY 2024, and near 40% over the next decade, for science agencies like the National Institutes of Health, the National Science Foundation, and NASA.
Summary By establishing a self-sustaining fund to incentivize pharmaceutical companies to develop new and improved treatment protocols using low-cost, off-patent and unmonopolizable therapies, billions of dollars in cost savings could be realized by US government payers and health insurers in a financially “de-risked” manner while improving quality of care —truly a win/win opportunity. Currently, pharmaceutical companies […]
Development aid can support local businesses, improve outcomes, and cut costs. Here’s how a Supply Chain Commercialization Fund can work with the private sector and build resilient health supply chains in Africa.